CN1273851A - Chinese medicine for treating intraocular hemorrhage - Google Patents
Chinese medicine for treating intraocular hemorrhage Download PDFInfo
- Publication number
- CN1273851A CN1273851A CN99112946A CN99112946A CN1273851A CN 1273851 A CN1273851 A CN 1273851A CN 99112946 A CN99112946 A CN 99112946A CN 99112946 A CN99112946 A CN 99112946A CN 1273851 A CN1273851 A CN 1273851A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- intraocular hemorrhage
- treatment
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating intraocular hermorrhage is prepared from 12 Chinese-medicinal materials including Dragon's bone, oyster shell, carbonized hair, rehmannia root, red sage root, etc. Its advantage is high curative effect.
Description
What the present invention relates to is a kind of raw-material pharmaceutical product that contains.
Intraocular hemorrhage is a kind of oculopathy that a kind of ophthalmology is common and treatment is rather thorny.The general conventional method that adopts is treated, and promptly stops blooding, promotes to absorb causal treatment.But therapeutic effect is not very good, has quite a few patient to leave over machine dissipating rashes old focus and corresponding defect of visual field, finally causes part visual loss or blind.
The object of the present invention is to provide and a kind ofly treat that intraocular hemorrhage is effective, the Chinese medicine of the treatment intraocular hemorrhage that has no side effect.
The object of the present invention is achieved like this: it contains Os Draconis 25-50 part, the male 25-50 of going through part, Haematitum 20-50 part, Crinis Carbonisatus 5-10 part, Radix Rehmanniae 15-20 part, Radix Salviae Miltiorrhizae 15-25 part, Cortex Moutan 15-25 part, Radix Angelicae Sinensis 15-20 part, Rhizoma Chuanxiong 10-20 part, Radix Paeoniae Rubra 10-20 part, CAIHU 10-20 part, Radix Curcumae 10-20 part.
The invention has the advantages that: intraocular hemorrhage motherland medical science is thought escape of blood from meridians, and overflow is in order, belongs to hyperactivity of fire caused by deficiency of YIN more and causes bleeding due to blood-heat, " blood flow is excessive ".Also have because of QI failing to control blood, blood do not have comply with and cause hemorrhage.So the present invention has selected the Drug therapy principle of replenishing YIN and removing heat, astringing to arrest bleeding, blood circulation promoting and blood stasis dispelling, regulating qi and dredging collateral for use, so receive excellent curative.Wherein contrary, the cooling blood for hemostasis in Haematitum suppressing the hyperactive liver town; Os Draconis, Concha Ostreae, the astringent or styptic treatment for spontaneous sweating convergence of Crinis Carbonisatus and stop blooding, the LONGMU chemical analysis contains CaCO
3, experimental results show that CaCO
3Anastalsis is stronger; Radix Salviae Miltiorrhizae, Cortex Moutan, Rhizoma Chuanxiong, Radix Paeoniae Rubra cooling blood for hemostasis, blood circulation promoting and blood stasis dispelling, adjustment capillary permeability, microcirculation improvement promotes intraocular hemorrhage to absorb; CAIHU, the Radix Curcumae eliminating stagnation " gas promoting the circulation of blood also go " of regulating the flow of vital energy, Radix Rehmanniae replenishing YIN and removing heat because of it is nourshing Yin and drynsessmoistening prescription, has been alleviated the dry puckery of LONGMU.Each component cooperatively interacts, and more becomes reasonable.Be used for the treatment of intraocular hemorrhage, intraocular hemorrhage is absorbed, the optical fundus does not have the sharp trace of staying (having except the machine dissipating rashes before the treatment), and vision returns to the preceding level of disease substantially.According to hemorrhage degree or different hemorrhage phases, can also increase suitable composition in the product of the present invention, make its better efficacy.
For example the present invention is done more detailed description below:
Example 1, press 25 parts of Os Draconis, 25 parts of Concha Ostreaes, 20 parts of Haematitums, 5 parts of Crinis Carbonisatus, 15 parts in the Radix Rehmanniae, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Cortex Moutans, 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Chuanxiongs, 10 parts of Radix Paeoniae Rubra, 10 parts of CAIHU, 10 parts of Radix Curcumaes, ratio prepare raw material, pulverize the back fill and become capsule.
Example 2, press 50 parts of Os Draconis, 50 parts of Concha Ostreaes, 50 parts of Haematitums, 10 parts of Crinis Carbonisatus, 20 parts in the Radix Rehmanniae, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Cortex Moutans, 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Chuanxiongs, 20 parts of Radix Paeoniae Rubra, 20 parts of CAIHU, 20 parts of Radix Curcumaes, ratio prepare raw material, add the adjuvant of making honeyed pill after the pulverizing and make honeyed pill, every ball weighs 9 grams.
Example 3, press 40 parts of Os Draconis, 40 parts of Concha Ostreaes, 35 parts of Haematitums, 8 parts of Crinis Carbonisatus, 18 parts in the Radix Rehmanniae, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Cortex Moutans, 18 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Radix Paeoniae Rubra, 15 parts of CAIHU, 15 parts of Radix Curcumaes, ratio prepare raw material, pulverize the back fill and become capsule or make honeyed pill.
Example 4 on the basis of example 1,2,3, adds Radix Notoginseng powder 3-5 part.Early stage large tracts of land is fresh hemorrhage, and is hemorrhage before the nethike embrane, vitreous hemorrhage, in ooze, should be based on hemostasis, it is auxilliary invigorating blood circulation, the adding of Radix Notoginseng can be received better haemostatic effect.
Example 5 adds Concha Haliotidis 10-20 part, Semen Cassiae 10-15 part on the basis of example 1,2,3,4.Be suitable for that blood pressure is higher, use under the situation of excessive rising of liver-YANG.
Example 6 adds Semen Persicae 10-20 part, Flos Carthami 10-20 part, cattle sunset 10-20 part on the basis of example 1,2,3.It is auxilliary to invigorate blood circulation, to stop blooding, and microcirculation improvement promotes focus to absorb, relatively be suitable for not having mid-term fresh hemorrhage, the optical fundus is hemorrhage on a small quantity, the treatment of remote hemorrhage.
Example 7 adds Olibanum 10-15 part, Myrrha 10-15 part, rhizoma sparganic 10-15 part, Rhizoma Curcumae 10-15 part on the basis of example 6.It relatively is suitable for using under the heavier situation of blood stasis.
Example 8 adds Sargassum 5-10 part, Thallus Laminariae (Thallus Eckloniae) 5-10 part on the basis of example 6,7.It relatively is applicable to the machine dissipating rashes, soft sign of oozing out.
Example 9, example 1,2,3, the basis on add Radix Astragali 15-25 part, Radix Codonopsis 10-15 part, Radix Puerariae 15-25 part.It relatively is suitable for the treatment in ophthalmorrhagia later stage, and it has tonify deficiency in case the characteristics of evil multiple, nourishing the liver and kidney, benefiting qi and nourishing blood.
Example 10 adds Fructus Schisandrae Chinensis 10-15 part, Semen Cuscutae 10-15 part, Fructus Lycii 10-15 part on the basis of example 9.Be applicable to convalescent period,, improve visual function to stimulate visual cell.To leaving over the treatment of pigmentation, old focus.
Claims (8)
1, a kind of Chinese medicine for the treatment of intraocular hemorrhage is characterized in that: it contains Os Draconis 25-50 part, Concha Ostreae 25-50 part, Haematitum 20-50 part, Crinis Carbonisatus 5-10 part, Radix Rehmanniae 15-20 part, Radix Salviae Miltiorrhizae 15-25 part, Cortex Moutan 15-25 part, Radix Angelicae Sinensis 15-20 part, Rhizoma Chuanxiong 10-20 part, Radix Paeoniae Rubra 10-20 part, CAIHU 10-20 part, Radix Curcumae 10-20 part.
2, the Chinese medicine of treatment intraocular hemorrhage according to claim 1 is characterized in that: it also contains Radix Notoginseng powder 3-5 part.
3, the Chinese medicine of treatment intraocular hemorrhage according to claim 1 is characterized in that: it also contains Concha Haliotidis 10-20 part, Semen Cassiae 10-15 part.
4, the Chinese medicine of treatment intraocular hemorrhage according to claim 1 is characterized in that: it also contains Semen Persicae 10-20 part, Flos Carthami 10-20 part, cattle sunset 10-20 part.
5, the Chinese medicine of treatment intraocular hemorrhage according to claim 4 is characterized in that: it also contains Olibanum 10-15 part, Myrrha 10-15 part, rhizoma sparganic 10-15 part, Rhizoma Curcumae 10-15 part.
6, the Chinese medicine of treatment intraocular hemorrhage according to claim 4 is characterized in that: it also contains Sargassum 5-10 part, Thallus Laminariae (Thallus Eckloniae) 5-10 part.
7, the Chinese medicine of treatment intraocular hemorrhage according to claim 1 is characterized in that: it also contains Radix Astragali 15-25 part, Radix Codonopsis 10-15 part, Radix Puerariae 15-25 part.
8, the Chinese medicine of treatment intraocular hemorrhage according to claim 7 is characterized in that: it also contains Fructus Schisandrae Chinensis 10-15 part, Semen Cuscutae 10-15 part, Fructus Lycii 10-15 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99112946A CN1112208C (en) | 1999-05-18 | 1999-05-18 | Chinese medicine for treating intraocular hemorrhage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99112946A CN1112208C (en) | 1999-05-18 | 1999-05-18 | Chinese medicine for treating intraocular hemorrhage |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1273851A true CN1273851A (en) | 2000-11-22 |
CN1112208C CN1112208C (en) | 2003-06-25 |
Family
ID=5276188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99112946A Expired - Fee Related CN1112208C (en) | 1999-05-18 | 1999-05-18 | Chinese medicine for treating intraocular hemorrhage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1112208C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102836316A (en) * | 2012-09-19 | 2012-12-26 | 张劭茹 | Chinese medicine preparation for treating amblyopia |
CN104606541A (en) * | 2015-01-25 | 2015-05-13 | 邹洪胜 | Traditional Chinese medicine composition for treating hyphema |
CN106214750A (en) * | 2016-08-31 | 2016-12-14 | 青岛大学附属医院 | A kind of medicine for external use treating body surface internal hemorrhage |
CN107714994A (en) * | 2017-12-14 | 2018-02-23 | 阜阳市平衡医疗保健器械有限公司 | A kind of medicine for treating vitreous hemorrhage and preparation method thereof |
US11711469B2 (en) | 2021-05-10 | 2023-07-25 | International Business Machines Corporation | Contextualized speech to text conversion |
-
1999
- 1999-05-18 CN CN99112946A patent/CN1112208C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102836316A (en) * | 2012-09-19 | 2012-12-26 | 张劭茹 | Chinese medicine preparation for treating amblyopia |
CN102836316B (en) * | 2012-09-19 | 2014-07-02 | 张劭茹 | Chinese medicine preparation for treating amblyopia |
CN104606541A (en) * | 2015-01-25 | 2015-05-13 | 邹洪胜 | Traditional Chinese medicine composition for treating hyphema |
CN106214750A (en) * | 2016-08-31 | 2016-12-14 | 青岛大学附属医院 | A kind of medicine for external use treating body surface internal hemorrhage |
CN107714994A (en) * | 2017-12-14 | 2018-02-23 | 阜阳市平衡医疗保健器械有限公司 | A kind of medicine for treating vitreous hemorrhage and preparation method thereof |
US11711469B2 (en) | 2021-05-10 | 2023-07-25 | International Business Machines Corporation | Contextualized speech to text conversion |
Also Published As
Publication number | Publication date |
---|---|
CN1112208C (en) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102151325B (en) | Traditional Chinese medicine for treating breast diseases | |
CN101700383B (en) | Traditional Chinese medicine for curing ovarian cysts | |
CN104857157A (en) | Decoction medicine for treating endometrial hyperplasia and preparation method thereof | |
CN100358571C (en) | Hot compress plaster for treating mastosis and its preparing method | |
CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
CN103006879B (en) | Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof | |
CN1112208C (en) | Chinese medicine for treating intraocular hemorrhage | |
CN101239134A (en) | Speckle-removing medicinal composition | |
CN103550521A (en) | Traditional Chinese medicine composition for treating night sweat | |
CN105963450A (en) | Traditional Chinese medicine composition for treating dizziness and faintness | |
CN100387283C (en) | Chinese traditional medicine for treating diabetes retinopathy | |
CN104547553A (en) | Traditional Chinese medicine for treating nervous endocrine disorder | |
CN104257813B (en) | A kind of Chinese medicine composition of QI and blood regulating and preparation method thereof | |
CN104225282A (en) | Traditional Chinese medicine for treating postpartum headache | |
CN103432422B (en) | Traditional Chinese medicine for treating chronic gastritis | |
CN101912476A (en) | Chinese medicinal herbs for treating female menorrhagia disease | |
CN107737305B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
CN105521384A (en) | Gynecological medicine for treating pregnancy complications, and preparation method thereof | |
CN105796815A (en) | Kidney-reinforcing and bone-strengthening liquor and preparation method thereof | |
CN104958718A (en) | Medicine for treating infertility | |
CN103110852B (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat | |
CN104352767A (en) | Traditional Chinese medicine for treating cervicogenic headache | |
CN104127839A (en) | Yin dissipating paste | |
CN104225407A (en) | Obstetrics and gynecology drug for treating postnatal depression and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |